Notably, methylation of RAD51B has been associated with immune checkpoint expression and inflammatory signatures in HNSCC (40), and SYK is recognized as a downstream effector of EGFR signaling implicated in HNSCC development (35). This evidence concerns the gene RAD51B and head and neck squamous cell carcinoma.